One Hour From Power-On to Audit-Ready: Accucold and PharmaWatch Redefine Vaccine Refrigeration Monitoring
Cold Storage Compliance Made Easy With Advanced Wireless Environmental Temperature Monitoring
BRONX, NY, UNITED STATES, September 10, 2026 /EINPresswire.com/ -- PharmaWatch®, a trusted leader in real-time environmental monitoring systems for healthcare, and Accucold®, a premier manufacturer of vaccine and pharmaceutical cold storage, today announced that PharmaWatch's temperature monitoring platform will be available as a factory-installed option on select Accucold vaccine and pharmaceutical refrigeration units beginning Q4 2026. Building on the companies' partnership announced in October 2025, this marks the first commercially available product to come out of it.
Facilities that choose the option receive a unit that begins generating real-time temperature data and documentation supporting compliance with FDA 21 CFR Part 11 within one hour of being powered on. This option can be added to wide range of cold storage equipment, including CDC compliant vaccine refrigerators and freezers, BOD heated/refrigerated incubators, laboratory refrigeration, and ultra low temperature freezers.
For facilities managing vaccines, biologics, and other temperature-sensitive inventory, the addition closes a common gap: the days or weeks that typically pass between a refrigerator's delivery and a fully documented monitoring record. Choosing the PharmaWatch option means that record starts building itself as soon as the unit is powered on, rather than waiting on a separate installation project, a sourced sensor kit, or an IT ticket.
The joint offering includes:
• Select Accucold vaccine and pharmaceutical refrigerators and freezers, available with PharmaWatch monitoring as a factory-installed option
• Automated, real-time monitoring for temperature over a multi-carrier cellular network — no WiFi or IT setup required
• Documentation supporting FDA 21 CFR Part 11 compliance, generated automatically rather than compiled by hand
• NIST-traceable calibration linked to the device record, plus IQ/OQ/PQ (Installation Qualification, Operational Qualification, and Performance Qualification) validation included at no extra cost
• A five-day battery backup, so monitoring doesn't stop during a power outage
From hospitals and outpatient clinics to blood banks and vaccine distribution centers, the option gives facilities a way to close the gap between equipment delivery and an audit-ready cold chain record. This timing is crucial for meeting the busy flu vaccine season already in progress.
The monitoring option will be available on qualifying Accucold vaccine and pharmaceutical refrigeration and freezer models beginning Q4 2026. To learn more, visit www.accucold.com or www.pharmawatch.com.
About Accucold
Accucold®, a division of Felix Storch, Inc., is a leading manufacturer of medical and life science refrigeration equipment, offering a full line of refrigerators and freezers designed to meet CDC vaccine storage guidelines for healthcare, laboratory, pharmaceutical, and scientific environments. Felix Storch, Inc. was founded in 1969, is ISO 9001:2015 certified, and operates an ISO/IEC 17025:2017 accredited calibration laboratory. Learn more at www.accucold.com.
About PharmaWatch
PharmaWatch is an automated, real-time environmental monitoring system purpose-built for regulated healthcare. For more than 15 years, PharmaWatch has protected temperature-sensitive inventory for blood banks, hospitals, pharmacies, laboratories, and pharmaceutical manufacturers across 43 states, with international deployments in Australia, Canada, Israel, and Mexico. PharmaWatch supports compliance with FDA 21 CFR Part 11, GxP, and cGMP requirements. PharmaWatch is a product of AmericanPharma Technologies, Inc. Learn more at www.pharmawatch.com.
EMILY INTRAVIA
Accucold Div. of Felix Storch, Inc.
+1 718-766-7109
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

